EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 84 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $9,417 | -24.0% | 10,500 | -0.0% | 0.00% | – |
Q4 2022 | $12,392 | -84.7% | 10,502 | -2.2% | 0.00% | – |
Q3 2022 | $81,000 | +22.7% | 10,737 | +1.8% | 0.00% | – |
Q2 2022 | $66,000 | -96.1% | 10,545 | -92.4% | 0.00% | -100.0% |
Q4 2020 | $1,702,000 | +62.2% | 138,481 | +7.4% | 0.00% | 0.0% |
Q3 2020 | $1,049,000 | -16.5% | 128,952 | -1.4% | 0.00% | 0.0% |
Q2 2020 | $1,256,000 | +63.5% | 130,803 | +15.8% | 0.00% | 0.0% |
Q1 2020 | $768,000 | -45.5% | 112,999 | +19.5% | 0.00% | 0.0% |
Q4 2019 | $1,409,000 | +1.4% | 94,561 | -30.3% | 0.00% | 0.0% |
Q3 2019 | $1,390,000 | – | 135,597 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 393,975 | $120,162 | 0.00% |
XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
DRW Securities, LLC | 120,365 | $37 | 0.00% |
DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |